Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebocontrolled multicenter trial (original) (raw)

Cited by

Effects of simvastatin in abdominal sepsis in rats

Cinthia Souza

Acta Cirurgica Brasileira, 2006

downloadDownload free PDFView PDFchevron_right

Continuous plasmafiltration in sepsis syndrome

Alistair Stewart

Critical Care Medicine, 1999

downloadDownload free PDFView PDFchevron_right

Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO

Hermann Ostermann

Annals of Hematology, 2006

downloadDownload free PDFView PDFchevron_right

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

Anna Simon

Nature Reviews Drug Discovery, 2012

downloadDownload free PDFView PDFchevron_right

Bayesian estimation of cost-effectiveness ratios from clinical trials

Alan Moskowitz, Daniel Heitjan

Health Economics, 1999

downloadDownload free PDFView PDFchevron_right

The role of the cell-cell interactions in cancer progression

ewa bartnik

Journal of Cellular and Molecular Medicine, 2015

downloadDownload free PDFView PDFchevron_right

Cardiac Fibroblasts Contribute to Myocardial Dysfunction in Mice with Sepsis: The Role of NLRP3 Inflammasome Activation

Claudio Martin

PLoS ONE, 2014

downloadDownload free PDFView PDFchevron_right

Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis

Simon McArthur, Chun Ma

Proceedings of the National Academy of Sciences of the United States of America, 2014

downloadDownload free PDFView PDFchevron_right

ATF3 Protects against LPS-Induced Inflammation in Mice via Inhibiting HMGB1 Expression

Heng Lin

Evidence-Based Complementary and Alternative Medicine, 2013

downloadDownload free PDFView PDFchevron_right

Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention

D. Neil Granger

British Journal of Pharmacology, 1999

downloadDownload free PDFView PDFchevron_right

Distinctive Cytokines as Biomarkers Predicting Fatal Outcome of Severe Staphylococcus aureus Bacteremia in Mice

Louis Boon

PLoS ONE, 2013

downloadDownload free PDFView PDFchevron_right

The Multifaceted Effects of Polysaccharides Isolated from Dendrobium huoshanense on Immune Functions with the Induction of Interleukin-1 Receptor Antagonist (IL-1ra) in Monocytes

Alice Yu

PLoS ONE, 2014

downloadDownload free PDFView PDFchevron_right

The role of interleukin-1 in general pathology

Ryu Shiraishi

downloadDownload free PDFView PDFchevron_right

Antibody-modified conduits for highly selective cytokine elimination from blood

Andre Shomorony

JCI Insight, 2018

downloadDownload free PDFView PDFchevron_right

Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)

Marcus Hentrich

Annals of Hematology, 2014

downloadDownload free PDFView PDFchevron_right

Re-Evaluating Biologic Pharmacotherapies that Target the Host Response during Sepsis

Ethan Anderson

International Journal of Molecular Sciences

downloadDownload free PDFView PDFchevron_right

Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure

Moreno Tresoldi

Frontiers in immunology, 2017

downloadDownload free PDFView PDFchevron_right

Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019

abdullah alahmed

Critical Care Explorations, 2020

downloadDownload free PDFView PDFchevron_right

Blocking Interleukin-1 in Rheumatic Diseases

Raphaela Goldbach-mansky

Annals of the New York Academy of Sciences, 2009

downloadDownload free PDFView PDFchevron_right

Minireview: Therapeutic intervention in sepsis with antibody to endotoxin: is there a future?

Alan Cross

Journal of Endotoxin Research, 1994

downloadDownload free PDFView PDFchevron_right

Interleukin-1 receptor antagonist as a biomarker of sepsis in neutropenic haematological patients

Auni Juutilainen

European Journal of Haematology, 2018

downloadDownload free PDFView PDFchevron_right

Unopposed Interleukin-1 is Necessary for Increased Plasma Cytokine and Eicosanoid Levels to Develop in Severe Sepsis

Collin Brathwaite

Annals of Surgery, 1997

downloadDownload free PDFView PDFchevron_right

Distinct Roles of Hepatocyte- and Myeloid Cell-Derived IL-1 Receptor Antagonist during Endotoxemia and Sterile Inflammation in Mice

Emiliana Rodriguez

The Journal of Immunology, 2010

downloadDownload free PDFView PDFchevron_right

The Preferential Use of Anakinra in Various Settings of FMF: A Review Applied to an Updated Treatment-Related Perspective of the Disease

Merav Lidar

International Journal of Molecular Sciences

downloadDownload free PDFView PDFchevron_right

Initial levels of organ failure, microbial findings and mortality in intensive care-treated primary, secondary and tertiary sepsis

Markus Castegren

Critical Care and Resuscitation

downloadDownload free PDFView PDFchevron_right